Skip to main content
Gene-based association identifies SPATA13-AS1 as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groups
Published Web Location
http://europepmc.org/articles/PMC4098013?pdf=renderNo data is associated with this publication.
Abstract
Inhaled short-acting beta-agonist (SABA) medication is commonly used in asthma patients to rapidly reverse airway obstruction and improve acute symptoms. We performed a genome-wide association study of SABA medication response using gene-based association
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.